EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSAOCG00000021645
Gene Symbol: GRIK4
3 Cross references
247 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSAOCG00000013789
Gene Symbol: GRIK5
3 Cross references
263 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSAOCG00000023957
Gene Symbol: GRIK5
3 Cross references
258 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSAOCG00000004621
Gene Symbol: GRM2
3 Cross references
210 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSAOCG00000021348
Gene Symbol: GRM4
3 Cross references
214 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSAOCG00000023110
Gene Symbol: GRM4
3 Cross references
200 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSAOCG00000001586
Gene Symbol: GRM5
3 Cross references
216 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSAOCG00000014969
Gene Symbol: LOC111588065
3 Cross references
252 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSAOCG00000004679
Gene Symbol: LOC111585856
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSAOCG00000000689
Gene Symbol: LOC111577643
3 Cross references
254 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSAOCG00000016721
Gene Symbol: LOC111575136
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSAOCG00000021970
Gene Symbol: LOC111571550
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).